Market Overview

The Global Precision Medicine Market was valued at USD 35,801.3 million in 2023 and is expected to reach USD 88,011.5 million by 2031 while growing at a CAGR of 11.9% during the forecast period (2024-2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Market Dynamics

This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global precision medicine market growth. Precision medicine is a novel approach to disease treatment and prevention that considers the unique variations in genes, environment, and lifestyle for each individual. This method enables doctors and researchers to more accurately determine which treatment and prevention strategies will be effective for specific groups of people with particular diseases.

The rise in chronic diseases and genetic disorders, along with increasing demand for personalized treatment and supportive government initiatives, drive market growth. However, high costs and regulatory and reimbursement challenges hinder this growth.

Furthermore, the global precision medicine industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.

Segmentation – By Type Analysis

The Global Precision Medicine Market is segmented among Inhibitor Drugs, Monoclonal Antibodies, Cell & Gene Therapy, Antiviral & Anti-retroviral Drugs, and Other Therapeutic Products, based on Type. In 2023, Inhibitor Drugs accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Segmentation – By Indication Analysis

The Global Precision Medicine Market is segmented among Oncology, Rare Diseases, Ingectious Diseases, Hematological Disorders, and Other Indications, based on Indication. In 2023, Oncology accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Global Precision Medicine Market: Regional Analysis

Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report

Competitive Landscape

Some of the key players operating in the market are Hoffmann-La Roche Ltd, Novartis AG, Pfizer Inc., Bristol Myers Squibb, AstraZeneca, Gilead Sciences Inc., AbbVie Inc, Eli Lily and Company, GlaxoSmithKline Plc., Sanofi, Johnson & Johnson, Merck KGaA, and Amgen Inc.

Table of Contents:

1. Research Methodology and Market Scope

• Research Methodology

• Market Scope

2. Executive Summary

3. Global Precision Medicine Market Dynamics

• Drivers

• Restraints

• Opportunity

4. Global Precision Medicine Industry Analysis

• PEST Analysis

• Porter's Five Force Analysis

• Recent Deals Analysis

5. Global Precision Medicine Market Segmentation, By Type

• Global Precision Medicine Market Share Analysis, By Type

• Global Precision Medicine Market Growth Analysis, By Type

• Global Precision Medicine Market Trends, By Type

o Inhibitor Drugs

o Monoclonal Antibodies

o Cell & Gene Therapy

o Antiviral & Anti-retroviral Drugs

o Other Therapeutic Products

6. Global Precision Medicine Market Segmentation, By Indication

• Global Precision Medicine Market Share Analysis, By Indication

• Global Precision Medicine Market Growth Analysis, By Indication

• Global Precision Medicine Market Trends, By Indication

o Oncology

o Rare Diseases

o Ingectious Diseases

o Hematological Disorders

o Other Indications

7. Global Precision Medicine Market Segmentation, By End User

• Global Precision Medicine Market Share Analysis, By End User

• Global Precision Medicine Market Growth Analysis, By End User

• Global Precision Medicine Market Trends, By End User

o Hospitals and Clinics

o Home care settings

8. Global Precision Medicine Market Segmentation, By Region

• Global Precision Medicine Market Share Analysis, By Region

• Global Precision Medicine Market Growth Analysis, By Region

• Global Precision Medicine Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

9. Competitive Landscape

• Hoffmann-La Roche Ltd.*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

• Novartis AG

• Pfizer Inc.

• Bristol Myers Squibb

• AstraZeneca

• Gilead Sciences Inc.

• AbbVie Inc

• Eli Lily and Company

• GlaxoSmithKline Plc.

• Sanofi

• Johnson & Johnson

• Merck KGaA

• Amgen Inc

*Similar analysis will be provided for each company listed above.